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Effects of CXCR4 siRNA/dextran-spermine nanoparticles on CXCR4 expression and 
serum LDH levels in a mouse model of colorectal cancer metastasis to the liver. 
ABSTRACT 
Liver metastasis is the main cause of mortality related to colorectal cancer. CXCR4 is 
necessary for the outgrowth of colon cancer micrometastases. In oncology, it has been 
demonstrated that several human tumors release lactate dehydrogenase (LDH) into the 
circulation. CXCR4 gene expression and serum LDH levels are often increased in patients 
with colorectal cancer. Despite technological advances in cancer therapy, five-year overall 
survival is still around 50%. Therefore, better treatment needs to be developed. RNA 
interference (RNAi) is a modern and powerful tool for inhibition of gene expression. 
However, the rate-limiting step in this technology is effective delivery of RNAi agents. We 
have investigated a novel strategy of CXCR4 siRNA therapy and its effect on serum LDH 
levels in a BALB/C mouse model of colorectal cancer metastasis to the liver. Hepatic 
metastasis was established by injecting a CT26.WT mouse colon carcinoma cell line via the 
tail vein. Our results demonstrated that CXCR4 siRNA/ dextran-spermine nanoparticles 
achieved high silencing efficiency with low toxicity. Favorable localization of the 
nanoparticles was confirmed with CXCR4 gene expression in the liver, that was correlated 
with serum LDH levels. More research will be needed to determine the effect of CXCR4 
silencing on serum LDH levels, which may be a useful marker for predicting liver metastasis 
in colorectal cancer. 
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